Search

everythinglearnresearchcommunity

for

Search:↓

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Spironolactone effectively makes hair shafts thinner in women with excessive hair growth.

People with acne have more CD4+ immune cells in their skin than healthy people.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

Alopecia linked to higher anxiety and personality disorders.

Aldactone effectively reduces hair thickness in women with excessive hair growth, both alone and with other treatments.

PCOS is a common condition in women that causes various symptoms and health issues, treatable with lifestyle changes and medication.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

Trichotillometry is a reliable method to measure hair strength and assess hair loss treatments.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Women with diffuse hair loss often have lower iron and vitamin D levels, but their thyroid function is typically normal.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Iron deficiency may contribute to chronic hair loss in premenopausal women.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Older age and certain lifestyles are linked to thinner, weaker hair, while how you see your hair relates to its thickness.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

The document concludes that proper diagnosis and treatment of nonscarring alopecias can improve quality of life and hair regrowth is possible as the hair follicle remains intact.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.